Showing results (11-20 of 79) with videos related to
Sort By:
Pageof 8
The Journal of Allergy and Clinical Immunology|March 1, 2011
Drug hypersensitivity: pharmacogenetics and clinical syndromesElizabeth J Phillips, Wen-Hung Chung, Maja Mockenhaupt, et al.Science (New York, N.Y.)|May 25, 2002
Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population levelCorey B Moore, Mina John, Ian R James, et al.Cell Metabolism|July 14, 2016
Homeostatic Responses Regulate Selfish Mitochondrial Genome Dynamics in C. elegansBryan L Gitschlag, Cait S Kirby, David C Samuels, et al.The Laryngoscope|February 2, 2023
Human Leukocyte Antigen Genotyping of Idiopathic Subglottic StenosisMatthew L Rohlfing, Alexander T Hillel, Elizabeth Wohler, et al.Antiviral Therapy|October 2, 2003
Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipientsCraig S Pace, Annalise M Martin, Emma L Hammond, et al.European Journal of Immunology|November 9, 2023
Underrepresentation of activating KIR gene expression in single-cell RNA-seq data is due to KIR gene misassignmentEric Alves, Abha Chopra, Ramesh Ram, et al.Genes and Immunity|November 18, 2016
HLA Class I and II alleles, heterozygosity and HLA-KIR interactions are associated with rates of genital HSV shedding and lesionsAmalia Magaret, Lichun Dong, Mina John, et al.Medrxiv : the Preprint Server for Health Sciences|November 18, 2021
Minimal in-school SARS-CoV-2 transmission with strict mitigation protocols at two independent schools in Nashville, TNLauren S Peetluk, Peter F Rebeiro, Kathryn M Edwards, et al.Tuberculosis (Edinburgh, Scotland)|November 29, 2020
Human leukocyte antigen associations with protection against tuberculosis infection and disease in human immunodeficiency virus-1 infected individuals, despite household tuberculosis exposure and immune suppressionFaheem Seedat, Ian James, Shayne Loubser, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 7, 2003
Randomized, controlled, 48-week study of switching stavudine and/or protease inhibitors to combivir/abacavir to prevent or reverse lipoatrophy in HIV-infected patientsMina John, Elizabeth J McKinnon, Ian R James, et al.Pageof 8